Eupraxia Pharmaceuticals (EPRX) Net Equity Issued and Repurchased (2023 - 2026)
Eupraxia Pharmaceuticals' Net Equity Issued and Repurchased was $49.25 million in the quarter ended Jun 30, 2026, compared with $620,344 a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eupraxia Pharmaceuticals' Net Equity Issued and Repurchased was $122.62 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at $73.89 million, up 223.3% from the prior year.
- Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 90.8% (years ended Dec 2022 to Dec 2025).
- In earlier years, Net Equity Issued and Repurchased was $22.85 million in the year ended Dec 31, 2024 (+336.0%), $5.24 million in the year ended Dec 31, 2023 (-50.7%) and $10.64 million in the year ended Dec 31, 2022.
- Quarterly Net Equity Issued and Repurchased has moved between -$22.52 million (the quarter ended Sep 30, 2024) and $73.25 million (the quarter ended Dec 31, 2025) over five years.
- Per Business Quant data, EPRX's Net Equity Issued and Repurchased in the three quarters before the quarter ended Jun 30, 2026 was $113,855 (quarter ended Mar 31, 2026), $73.25 million (quarter ended Dec 31, 2025) and $3,039 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | 49.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.25 Mn |
| Mar 31, 2026 | 113,855.00 |
| Dec 31, 2025 | 73.25 Mn |
| Sep 30, 2025 | 3,039.00 |
| Jun 30, 2025 | 620,344.00 |
| Mar 31, 2025 | 13,517.00 |
| Dec 31, 2024 | 22.52 Mn |
| Sep 30, 2024 | -22.52 Mn |
| Mar 31, 2024 | 22.85 Mn |
| Dec 31, 2023 | -1.00 |
| Sep 30, 2023 | 420,997.00 |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 229,536.00 |
API Access
Eupraxia Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();